Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma
Not Applicable
Not yet recruiting
- Conditions
- Relapsed Peripheral T-Cell LymphomaRefractory Peripheral T-Cell Lymphoma
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT06671717
- Locations
- 🇨🇳
Peking University, Institute of Hematolgoy, Beijing,, Beijing, China
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Phase 1
Not yet recruiting
- Conditions
- Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia
- Interventions
- Biological: CAR-T（RD140 injection）
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT06655519
Rapid DFLC Response Predict CHR in AL Amyloidosis
Recruiting
- Conditions
- Systemic AL Amyloidosis
- Interventions
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06627309
- Locations
- 🇨🇳
Fuxing Hospital affiliated to Capital Medical University, Beijing, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, Beijing, China
Treatment Duration of IPA
Active, not recruiting
- Conditions
- Invasive AspergillosisAntifungal Therapy
- First Posted Date
- 2024-09-04
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06583512
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
Not Applicable
Recruiting
- Conditions
- Relapsed Adult ALLB-cell Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic LeukemiaRelapsed Pediatric ALL
- Interventions
- Biological: Senl_B19 autologous CAR-T (S1904) treatment
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT06581081
- Locations
- 🇨🇳
Peking University People'S Hospital, Beijing, Beijing, China
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06577909
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
Recruiting
- Conditions
- Myelodysplastic Syndromes
- Interventions
- Other: Multiparametric Flow Cytometry for the detection of Myelodysplastic syndromes with Measurable residual disease
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 163
- Registration Number
- NCT06569095
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳Wuhan TongJi Hospital, Wuhan, China
The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
Not yet recruiting
- Conditions
- CLL
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06557304
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Not Applicable
Not yet recruiting
- Conditions
- Mismatch Repair DeficiencyEndometrioid CarcinomaEndometrial Cancer
- Interventions
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06549855
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
Phase 2
Not yet recruiting
- Conditions
- Pregnancy RelatedProtein S Deficiency
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT06531525
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing/Beijing, China
© Copyright 2025. All Rights Reserved by MedPath